CRL

Charles River Laboratories International
CRL

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$7.34B
EV
$10.15B
Shares Outstanding
49.12M
Beta
1.48

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
$156.14
P/E 2025E
15.53x
P/Revenue 2025E
1.88x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Charles River Laboratories International, Inc.

gainify
CRL

Charles River Laboratories International, Inc.

CRL

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services ...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Foster, James

Employees

19,400

IPO Date

2000-06-23

Headquarters

251 Ballardvale Street, Wilmington, Massachusetts, 01887, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.